ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2017 ACR/ARHP Annual Meeting

November 3-8, 2017 in San Diego, CA

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u v [w] x y z
  • Abstract Number: 2611
    Walk SLE – a Pilot Study Exploring Walk with Ease (WWE), a Self-Directed Walking Program, in Lupus Patients
  • Abstract Number: 2190
    War and Arthritis
  • Abstract Number: 1239
    Web Based Educational Intervention to Improve Cardiovascular Disease Knowledge Among RA Patients
  • Abstract Number: 2524
    Weight Change before and after Diagnosis in Patients with Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis
  • Abstract Number: 2376
    Weight Histories Expose the Systematic Underestimation of the Risks of Obesity on Mortality in Rheumatoid Arthritis
  • Abstract Number: 2556
    Were Moll and Wright Right?
  • Abstract Number: 346
    What Are We Measuring? Influence of Contextual Factors on RAPID3 Scores in Psoriatic Arthritis
  • Abstract Number: 2971
    What Do Reduced 28 Joint Counts Miss in Patients with Psoriatic Arthritis?
  • Abstract Number: 131
    What Does It Mean to Have Rheumatoid Arthritis Now? a Current Burden of Disease Assessment in the United States
  • Abstract Number: 1249
    What Factors Predict Good Patient Experiences of Switching from Reference Etanercept (EnbrelTM) to an Etanercept Biosimilar (BenepaliTM) in a South West London General Hospital?
  • Abstract Number: 979
    What Have We Learned from Trajectory Analysis of Clinical Outcomes in Osteoarthritis?
  • Abstract Number: 343
    What Is the Impact of Functional Medicine on Patient Reported Outcomes in Inflammatory Arthritis?
  • Abstract Number: 205
    What Is the Value of the Prior Authorization Process in Specialty Drug Therapy?
  • Abstract Number: 1029
    What to Measure after Arthroplasty? Confirmation of a Core Domain Set
  • Abstract Number: 2484
    When Etanercept Switch Fails – Clinical Considerations
  • Abstract Number: 2514
    When Should Lateral Dexa be Used to Measure Spine Bone Mineral Density in Axial Spondyloarthritis Patients: A Cross-Sectional Study
  • Abstract Number: 249
    Where to Look for Uric Acid Crystals? Results from a Norwegian Ultrasound Study
  • Abstract Number: 1174
    Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?
  • Abstract Number: 592
    Which Imaging Outcomes for AxSpA Are Most Sensitive to Change? a 5-Year Analysis of the DESIR Cohort
  • Abstract Number: 83
    Whole Blood Stimulations Identify Elevated T Cell Cytokines and Altered Granulocyte/Dendritic Cell Signaling in SLE Patients with Variable Disease Activity
  • Abstract Number: 2618
    Why Aren’t All Patients with SLE Taking Hydroxychloroquine? A Retrospective Chart Review
  • Abstract Number: 2852
    Widespread Pain Prior to Total Knee Replacement (TKR) Is Associated with Increased Risk of No Clinical Improvement in Pain Among Women
  • Abstract Number: 2191
    Widespread Regulation of Gene Expression By Glucocorticoids in Chondrocytes from OA Patients As Determined By NGS-Based Genome Wide Expression Analysis
  • Abstract Number: 2929
    WNT5A Promotes Tissue Fibrosis By Wnt/PCP-Dependent Activation of Latent TGF-β
  • Abstract Number: 2388
    Women and Men with Rheumatoid Arthritis Present with Different Risks for Glucocorticoid-Related Comorbidities
  • Abstract Number: 2237
    Work Productivity and Activity Impairment in Primary Sjögren’s Syndrome
  • Abstract Number: 363
    Work Productivity Benefit in Patients with Rheumatoid Arthritis Initiating Etanercept in the United States
Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u v [w] x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Atlanta, Georgia

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.